iShares Biotechnology ETF (NASDAQ:IBB) Shares Acquired by SlateStone Wealth LLC

SlateStone Wealth LLC grew its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 3.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 26,356 shares of the financial services provider’s stock after acquiring an additional 906 shares during the quarter. SlateStone Wealth LLC’s holdings in iShares Biotechnology ETF were worth $3,580,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the business. Jacobi Capital Management LLC raised its position in iShares Biotechnology ETF by 3.7% during the third quarter. Jacobi Capital Management LLC now owns 2,539 shares of the financial services provider’s stock valued at $310,000 after acquiring an additional 91 shares in the last quarter. Geneos Wealth Management Inc. raised its position in iShares Biotechnology ETF by 16.7% during the third quarter. Geneos Wealth Management Inc. now owns 644 shares of the financial services provider’s stock valued at $79,000 after acquiring an additional 92 shares in the last quarter. PFG Investments LLC raised its position in iShares Biotechnology ETF by 4.8% during the third quarter. PFG Investments LLC now owns 2,013 shares of the financial services provider’s stock valued at $246,000 after acquiring an additional 93 shares in the last quarter. Huntington National Bank raised its position in iShares Biotechnology ETF by 7.4% during the third quarter. Huntington National Bank now owns 1,450 shares of the financial services provider’s stock valued at $177,000 after acquiring an additional 100 shares in the last quarter. Finally, HB Wealth Management LLC raised its position in iShares Biotechnology ETF by 5.9% during the fourth quarter. HB Wealth Management LLC now owns 1,892 shares of the financial services provider’s stock valued at $257,000 after acquiring an additional 105 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.3 %

IBB stock traded up $0.34 during trading on Wednesday, hitting $128.36. 98,759 shares of the company traded hands, compared to its average volume of 1,790,956. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $141.16. The stock’s 50-day simple moving average is $134.81 and its 200 day simple moving average is $129.75.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were given a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.39%. The ex-dividend date was Thursday, March 21st.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.